XML 63 R44.htm IDEA: XBRL DOCUMENT v3.22.4
Share-Based and Long-Term Incentive Plans (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Estimated Fair Value of Converted Stock Options Using Hull-White Model in Binomial Lattice Option Pricing Framework The estimated fair value of the converted stock options was determined using a Hull-White model in a binomial lattice option pricing framework with the following weighted average assumptions:

Stock price (closing stock price on March 14, 2021)

 

$

91.78

 

Weighted average fair value of converted stock options

 

$26.05 to $87.84

 

Risk-free interest rate

 

0.04% to 1.62%

 

Expected stock price volatility

 

50.06 % to 65.18%

 

Dividend yield

 

 

 

Term to expiration

 

0.25 years to 9.75 years

 

Summary of Stock Option Activity

The following table summarizes stock option activity during the year ended December 31, 2022:

 

 

 

 

 

 

 

 

Weighted Average

 

 

 

 

 

 

 

 

 

Weighted

 

 

Contractual Term

 

 

Aggregate

 

 

 

 

 

 

Average

 

 

Remaining

 

 

Intrinsic Value

 

 

 

Options

 

 

Exercise Price

 

 

(in years)

 

 

(in thousands)

 

Outstanding as of December 31, 2021

 

 

6,209,583

 

 

$

23.91

 

 

 

3.95

 

 

$

520,651

 

Exercised

 

 

(1,328,694

)

 

 

22.42

 

 

 

 

 

 

 

Forfeited

 

 

(43,690

)

 

 

53.90

 

 

 

 

 

 

 

Expired

 

 

(6,967

)

 

 

30.81

 

 

 

 

 

 

 

Outstanding as of December 31, 2022

 

 

4,830,232

 

 

 

24.04

 

 

 

2.91

 

 

$

433,552

 

Exercisable as of December 31, 2022

 

 

4,709,528

 

 

$

23.31

 

 

 

2.80

 

 

$

426,145

 

 

Summary of Outstanding Stock Options

The following table summarizes the Company’s outstanding stock options at December 31, 2022:

 

 

Options Outstanding

 

 

Options Exercisable

 

 

 

 

 

 

 

 

 

Weighted Average

 

 

 

 

 

Weighted

 

 

Weighted Average

 

 

 

 

 

 

Weighted

 

 

Remaining

 

 

 

 

 

Average

 

 

Remaining

 

 

 

Number of options

 

 

Average

 

 

Contractual

 

 

Number

 

 

Exercise

 

 

Contractual

 

Exercise Price Ranges

 

outstanding

 

 

Exercise Price

 

 

Term (in years)

 

 

Exercisable

 

 

Price

 

 

Term (in years)

 

$2.01 - $4.00

 

 

2,350

 

 

$

3.74

 

 

 

0.85

 

 

 

2,350

 

 

$

3.74

 

 

 

0.85

 

$4.01- $8.00

 

 

44,210

 

 

 

4.83

 

 

 

4.42

 

 

 

44,210

 

 

 

4.83

 

 

 

4.42

 

$8.01 - $12.00

 

 

33,711

 

 

 

8.78

 

 

 

2.23

 

 

 

32,141

 

 

 

8.79

 

 

 

2.04

 

$12.01 - $17.00

 

 

819,991

 

 

 

14.27

 

 

 

3.84

 

 

 

805,871

 

 

 

14.25

 

 

 

3.79

 

$17.01 - $22.00

 

 

467,094

 

 

 

17.98

 

 

 

3.56

 

 

 

467,094

 

 

 

17.98

 

 

 

3.56

 

$22.01 - $28.00

 

 

1,565,300

 

 

 

22.30

 

 

 

2.33

 

 

 

1,548,379

 

 

 

22.26

 

 

 

2.29

 

$28.01 - $36.00

 

 

1,719,794

 

 

 

28.60

 

 

 

2.35

 

 

 

1,719,794

 

 

 

28.60

 

 

 

2.35

 

$42.01 - $81.00

 

 

177,782

 

 

 

64.19

 

 

 

7.10

 

 

 

89,689

 

 

 

64.19

 

 

 

6.95

 

 

 

 

4,830,232

 

 

$

24.04

 

 

 

2.91

 

 

 

4,709,528

 

 

$

23.31

 

 

 

2.80

 

Summary of Restricted Stock Unit Activity

The following table summarizes restricted stock unit activity for the year ended December 31, 2022:

 

 

 

 

 

Weighted Average

 

 

 

Number of

 

 

Grant-Date Fair

 

 

 

Units

 

 

Value Per Unit

 

Outstanding as of December 31, 2021

 

 

4,412,681

 

 

$

52.67

 

Granted

 

 

2,034,407

 

 

 

97.91

 

Vested

 

 

(2,487,884

)

 

 

45.08

 

Forfeited

 

 

(492,932

)

 

 

79.93

 

Outstanding as of December 31, 2022

 

 

3,466,272

 

 

$

80.84

 

Summary of Performance Stock Unit Awards (PSUs) Activity

The following table summarizes performance stock unit awards (“PSUs”) activity for the year ended December 31, 2022:

 

 

 

 

 

Weighted

 

 

 

 

 

Recorded

 

 

 

 

 

 

Average

 

 

 

 

 

Weighted

 

 

 

 

 

 

Grant-Date

 

 

Average

 

 

Average

 

 

 

Number

 

 

Fair Value

 

 

Illiquidity

 

 

Fair Value

 

 

 

of Units

 

 

Per Unit

 

 

Discount

 

 

Per Unit

 

Outstanding as of December 31, 2021

 

 

1,528,216

 

 

 

 

 

 

 

 

 

 

Granted

 

 

309,470

 

 

$

138.41

 

 

 

4.65

%

 

$

131.98

 

Forfeited

 

 

(53,233

)

 

 

105.34

 

 

 

6.50

%

 

 

98.49

 

Vested

 

 

(1,006,112

)

 

 

35.47

 

 

 

6.04

%

 

 

33.32

 

Performance Based Adjustment (1)

 

 

455,243

 

 

 

49.75

 

 

 

7.83

%

 

 

45.85

 

Outstanding as of December 31, 2022

 

 

1,233,584

 

 

 

 

 

 

 

 

 

 

(1)
Represents adjustment based on meeting total shareholder return (“TSR”) performance at 200% for the PSUs that were awarded to key executive participants on January 4, 2019, meeting TSR performance at 200% for the PSUs awarded to key executive participants on January 4, 2020 and performance criteria meeting at 200% of R&D PSUs awarded to key executive participants on January 4, 2021.
Summary of Significant Valuation Assumptions Related to 2022 Relative TSR PSUs

All PSUs outstanding on December 31, 2022 may vest in a range of between 0% and 200%, with the exception of certain modified PSUs granted in 2020 and based on net sales which were capped at 150%. The Company accounts for all PSUs as equity-settled awards in accordance with ASC 718, Compensation-Stock Compensation. Because the value of the 2022 Relative TSR PSUs is dependent upon the attainment of a level of TSR, it requires the impact of the market condition to be considered when estimating the fair value on the grant date. As a result, the Monte Carlo model is applied and the most significant valuation assumptions used related to the 2022 Relative TSR PSUs during the year ended December 31, 2022, include:

Valuation date stock price

 

$

105.97

 

Expected volatility

 

 

45.01

%

Risk free rate

 

 

1.01

%

Summary of Share-Based Compensation Expense

The following table summarizes share-based compensation expense included in the Company’s consolidated statements of operations for the years ended December 31, 2022, 2021 and 2020 (in thousands):

 

 

 

For the Years Ended December 31,

 

 

 

2022

 

 

2021

 

 

2020

 

Cost of goods sold

 

$

8,913

 

 

$

8,699

 

 

$

7,203

 

Research and development

 

 

27,831

 

 

 

39,544

 

 

 

13,973

 

Selling, general and administrative

 

 

145,356

 

 

 

170,843

 

 

 

125,451

 

Total share-based compensation expense

 

$

182,100

 

 

$

219,086

 

 

$

146,627